Donald Notman
Net worth: 2 M $ as of 30/06/2026
Net worth: 2 M $ as of 30/06/2026
Donald Notman is Chief Operating Officer at Ocular Therapeutix, Inc. since 2026.
Formerly, Mr. Notman was Managing Director & Head-Private Capital Markets at Leerink Partners LLC.
From 2014 to 2017, Mr. Notman was Chief Financial Officer & Senior Vice President at Thrasos Therapeutics, Inc. Education includes an undergraduate degree from Middlebury College and an MBA from Tuck School of Business at Dartmouth.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/03/2026 | 184,662 ( 0.09% ) | 2 M $ | 30/06/2026 |
| Companies | Position | Start |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Chief Operating Officer | 29/08/2024 |
| Companies | Position | End |
|---|---|---|
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotheraputics for the treatment and prevention of kidney diseases | Director of Finance/CFO | 01/03/2017 |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Ocular Therapeutix, Inc.
Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Middlebury College
Middlebury College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tuck School of Business at Dartmouth
Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biotheraputics for the treatment and prevention of kidney diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions